Bleric Alcalá (B Alcalá Revilla)

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 3

Top Topics

Emergency Department

Decision Making

Top Venues

PharmacoEconomics

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Néboa Zozaya, Bleric Alcalá, P Arrazola Martínez, J R Chávarri Bravo, I Cuesta Esteve, Amós García Rojas, Federico M Torres, E Redondo Margüello, A Rivero Cuadrado, S Tamames Gómez, Javier Villaseca, Álvaro HIdalgo-Vega
Pathway towards an ideal and sustainable framework agreement for the public procurement of vaccines in Spain: a multi-criteria decision analysis. Human vaccines & immunotherapeutics 16 (11) (2020)
Jorge Mestre-Ferrandiz, Néboa Zozaya, Bleric Alcalá, Álvaro Hidalgo-Vega
Multi-Indication Pricing: Nice in Theory but Can it Work in Practice? PharmacoEconomics 36 (12) (2019)
Néboa Zozaya, Lucía Martínez-Galdeano, Bleric Alcalá, Jose Carlos Armario-Hita, Concepción Carmona, Y José Manuel Carrascosa, Pedro Herranz, María Jesús Lamas, Marta Trapero-Bertran, Álvaro Hidalgo-Vega
Determining the Value of Two Biologic Drugs for Chronic Inflammatory Skin Diseases: Results of a Multi-Criteria Decision Analysis. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 32 (3) (2018)